Life Science Company News

Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases

Read more ››
By: GlobeNewswire - 27 Sep 2023

Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®

Read more ››
By: GlobeNewswire - 27 Sep 2023

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)

Read more ››
By: GlobeNewswire - 27 Sep 2023

SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split

Read more ››
By: GlobeNewswire - 27 Sep 2023

Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application

Read more ››
By: GlobeNewswire - 27 Sep 2023

Cidara Therapeutics to Present New Data on Novel drug-Fc conjugate CD388 at IDWeek 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

Read more ››
By: GlobeNewswire - 27 Sep 2023

BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry

Read more ››
By: GlobeNewswire - 27 Sep 2023

LifeMD to Participate in Two Investor Conferences in October

Read more ››
By: GlobeNewswire - 27 Sep 2023

STRATA Skin Sciences to Present at Upcoming October Conferences

Read more ››
By: GlobeNewswire - 27 Sep 2023

Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 27 Sep 2023

Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development

Read more ››
By: GlobeNewswire - 27 Sep 2023

Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate

Read more ››
By: GlobeNewswire - 27 Sep 2023

Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology

Read more ››
By: GlobeNewswire - 27 Sep 2023

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023

Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023

Akari Therapeutics to Present at Emerging Growth Conference

Read more ››
By: GlobeNewswire - 27 Sep 2023

IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel  

Read more ››
By: GlobeNewswire - 27 Sep 2023

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

Read more ››
By: GlobeNewswire - 27 Sep 2023

Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g.

Read more ››
By: GlobeNewswire - 27 Sep 2023
Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Enhance your business development with Biotechgate